This may include reducing your dose, switching to a maintenance plan, or discontinuing medication while continuing healthy lifestyle habits
Snack at 3
Potent body weight loss and efficacy in a NASH animal model by a novel long-acting GLP-1/Glucagon/GIP triple-agonist (HM15211)
February 29, 2024 [17] Clinical Review Report: Semaglutide (Ozempic): (Novo Nordisk Canada Inc.): Indication: For the treatment of adult patients with type 2 diabetes mellitus to improve glycemic control, in combination with metformin (second-line treatment), and in combination with metformin and sulfonylurea (third-line treatment) [Internet]
A limitation of the single-dose trial was the apparent underestimation of semaglutide plasma concentrations with the applied LOCI assay due to a matrix effect
If you notice symptoms like a lump in your neck, changes in your voice, or trouble swallowing, its important to let your provider know